SEC Company Response from HCW Biologics Inc. (HCWB) (CIK 0001828673) (HCWB) — Jun 16, 2026
HCW Biologics Inc. (HCWB) (CIK 0001828673)
Date: June 16, 2026 · CIK: 0001828673 · Accession: 0001493152-26-028858
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296577
Letter
VIA EDGAR AND E-MAIL Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission F. Street, N.E. Washington, DC 20549-7010 Re: HCW Biologics Inc. Registration Statement on Form S-1; Commission File No. 333-296577
Dear Mr. Campbell:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, HCW Biologics Inc. (the "Company") hereby requests that the effectiveness of the above referenced Registration Statement on Form S-1 be accelerated by the U.S. Securities and Exchange Commission to 3:00 p.m. Eastern Time on Thursday, June 18, 2026, or as soon thereafter as is practicable.
The Company hereby authorizes James Groth or Jeny Zarmon of Clark Hill PLC to orally modify or withdraw this request for acceleration. Please contact Mr. Groth at (312) 701-6830 or Ms. Zarmon at (609) 785-2918 with any questions you may have concerning this request, and please notify them when this request for acceleration has been granted.
Thank you for your courtesy and cooperation in this matter.
Very
truly yours,
HCW
BIOLOGICS INC.
Show Raw Text
CORRESP 1 filename1.htm June 16, 2026 VIA EDGAR AND E-MAIL Alan Campbell Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549-7010 Re: HCW Biologics Inc. Registration Statement on Form S-1; Commission File No. 333-296577 Dear Mr. Campbell: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, HCW Biologics Inc. (the "Company") hereby requests that the effectiveness of the above referenced Registration Statement on Form S-1 be accelerated by the U.S. Securities and Exchange Commission to 3:00 p.m. Eastern Time on Thursday, June 18, 2026, or as soon thereafter as is practicable. The Company hereby authorizes James Groth or Jeny Zarmon of Clark Hill PLC to orally modify or withdraw this request for acceleration. Please contact Mr. Groth at (312) 701-6830 or Ms. Zarmon at (609) 785-2918 with any questions you may have concerning this request, and please notify them when this request for acceleration has been granted. Thank you for your courtesy and cooperation in this matter. Very truly yours, HCW BIOLOGICS INC. By: /s/ Hing Wong Hing Wong, Founder and CEO HCW Biologics acceleration request for S-1 June 2026 2929 N Commerce Parkway |Miramar, Florida 33025, USA |Phone 954-842-2024 | Fax 954-842-2037 |